Literature DB >> 3922394

Neurofibromatous dermal hypoplasia: a clinical, pharmacological and ultrastructural study.

J F Norris, A G Smith, P J Fletcher, T L Marshall, M J Hand.   

Abstract

Dermal hypoplasia is reported in three patients with neurofibromatosis. The areas of dermal hypoplasia failed to react to vasodilator stimuli and responded poorly to a vasoconstrictor stimulus. Histology of these lesions showed neurofibromatous tissue and at an ultrastructural level cells resembling perineurial cells were wrapped around dermal vessels. The poor vascular responses seen in these areas of neurofibromatous dermal hypoplasia might be due to the perineurial cells acting as a barrier to diffusion of the pharmacological agents and as a physical perivascular splint.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3922394     DOI: 10.1111/j.1365-2133.1985.tb02317.x

Source DB:  PubMed          Journal:  Br J Dermatol        ISSN: 0007-0963            Impact factor:   9.302


  3 in total

1.  The Nf1 tumor suppressor regulates mouse skin wound healing, fibroblast proliferation, and collagen deposited by fibroblasts.

Authors:  R P Atit; M J Crowe; D G Greenhalgh; R J Wenstrup; N Ratner
Journal:  J Invest Dermatol       Date:  1999-06       Impact factor: 8.551

Review 2.  Neurofibromatosis type 1.

Authors:  Kevin P Boyd; Bruce R Korf; Amy Theos
Journal:  J Am Acad Dermatol       Date:  2009-07       Impact factor: 11.527

3.  Factors Within the Endoneurial Microenvironment Act to Suppress Tumorigenesis of MPNST.

Authors:  Jo Anne Stratton; Peggy Assinck; Sarthak Sinha; Ranjan Kumar; Aaron Moulson; Natalya Patrick; Eko Raharjo; Jennifer A Chan; Rajiv Midha; Wolfram Tetzlaff; Jeff Biernaskie
Journal:  Front Cell Neurosci       Date:  2018-10-11       Impact factor: 5.505

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.